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Abstract 
BACKGROUND: There are a few literature data on the correlation between metabolic syndrome 
(MetS) and coronary disease among Iranian population. This study aimed to find relationship 
between MetS and severity of coronary artery disease (CAD) in presence of diabetes. 
METHODS: Total of 192 patients were consecutively enrolled in the study who were admitted to 
coronary care unit because of acute coronary syndrome (ACS) and then underwent coronary 
angiography. MetS was defined by Iranian criteria. A coronary atherosclerosis score was used to 
quantify the extent of atherosclerotic involvement. The relationship between MetS and 
angiographic CAD severity or clinical presentation was compared between them after adjusting 
for diabetes. 
RESULTS: Individuals with MetS (n = 125) had a higher prevalence of ST-elevation myocardial 
infarction (71% vs 30%, P < 0.001), multi-vessel disease (50% vs. 34%, P = 0.003), decreased 
ejection fraction (P = 0.001) and more severe angiographic stenosis based on both modified 
Gensini (P = 0.081) and syntax (P = 0.008) scores, compared to those without MetS. Syntax 
score showed statistically significant difference between two groups before (P = 0.021) and after 
adjustment for diabetes (P = 0.005). 
CONCLUSION: MetS was related to the severity of CAD both clinically and by angiographic scores 
but diabetes was a challenging factor and may independently increase the severity of CAD. 
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Introduction 
Metabolic syndrome (MetS) is considered as a major 
health problem in recent years and recognized by a 
cluster of risk factors related to diabetes and 
amplified risk of coronary artery disease (CAD).1,2 
Previous studies have shown that Asians have 
additional risk for development of MetS since the 
prevalence of abdominal obesity and diabetes are 
greater among them.3 Despite important 
controversy, the increased risk of cardiovascular 
diseases in subjects suffering from MetS has been 
established.4,5 Recent epidemiological and clinical 
studies have confirmed the association between 
MetS and increased risk of CAD,6,7 which is the 
leading cause of mortality. Morbidity and mortality 
from CAD are greater in patients with MetS; 
consequently, early evaluation of the risk of CAD in 
patients with MetS is necessary since it could lead to 
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change in lifestyle behavior and reducing CAD risk 
factors. Diabetes is considered as one of the 
complications of obesity and a strong risk factor for 
CAD.8-10 There is evidence that shows the duration 
of diabetes is associated with greater risk of acute 
coronary syndrome (ACS) and CAD.11-14 So this 
study was conducted to evaluate whether MetS 
could be associated with the coronary artery disease 
severity and to see whether the severity of coronary 
lesion was different in MetS patients with or 
without type 2 diabetes. 
Materials and Methods 
This cross-sectional study was done from 
February 2012 to March 2015 in Shahid Beheshti 
University of Medical Sciences, Tehran, Iran. 
Totally 192 patients were enrolled in the study, 
who were admitted to coronary care unit (CCU) 
due to chest pain, and subsequently underwent 
coronary angiography. Patients entered the study 
after obtaining written informed consent. Positive 
family history of coronary artery disease, current 
smoker or ex-smoker, subjects with high low-
density lipoprotein-cholesterol (LDL-C) (LDL 
level > 160 mg/dl and or under treatment for 
high LDL) and prior coronary artery bypass graft 
(CABG) or percutaneous coronary intervention 
(PCI) were considered as exclusion criteria. Data 
on social, demographic, personal and family 
medical history, and lifestyle (physical activity, 
smoking, alcohol intake, and diet) were obtained 
from either physical and laboratory examinations 
(anthropometric testing, blood sample laboratory 
analysis, and blood pressure measurements) or 
questionnaires. Triglyceride (TG), high-density 
lipoprotein-cholesterol (HDL-C) and fasting 
blood sugar (FBS) levels were measured by 
enzymatic methods (Pars Azmon commercial kits, 
Iran) based on previously published methods.15 
Blood pressure was measured twice in sitting 
position after five minutes resting. Waist 
circumference was measured with a flexible tape 
placed on a horizontal plane at the level of the iliac 
crest as seen from the anterior view.16  
Extent of coronary artery disease was assessed 
by modified Gensini and syntax scoring systems.  
On quantitative analyses of coronary 
angiograms (Quantcor QCA, version 4.0; Pie 
Medical Imaging, Maastricht, The Netherlands), 
the presence of stenosis ≥ 50% in diameter of 
major epicardial vessels was characterized as 
CAD (Gensini score > 1). 
The extent of CAD was quantified using the 
number of vessels with ≥ 50% stenosis and a 
coronary atherosclerosis score as mentioned 
below.17,18 
The syntax score system used to show the 
severity of CAD quantitates the complexity and the 
extent of CAD to aid clinicians in assessing early 
and late outcomes of PCI and CABG in patients 
with multivessel CAD and has become the 
preferred risk assessment tool for grading lesion 
complexity.19 
All statistical analyses were performed by SPSS 
(version 22.0, SPSS Inc., Chicago, IL, USA). 
Kolmogorov-Smirnov test and Q-Q plot were used 
to examine normality of data. Qualitative variables 
were expressed as numbers (percentages) and 
quantitative data was showed by mean and standard 
deviation (SD). Multiple logistic regression was used to 
compare the types of (ACS) and angiographic 
recommendations after adjustment for diabetes.  
P-values were considered significant at a level of  
< 0.05. 
Results 
Among 192 patients, 138 (71.9%) patients were 
male, and 125 (65%) patients fulfilled the criteria of 
MetS. Patients without MetS were significantly older 
than MetS group (P < 0.001). The prevalence of 
diabetes was 47%. Table 1 shows summary of 
clinical characteristics based on the presence of the 
MetS. Blood pressure, waist circumference, FBS, 
cholesterol (CHL), HDL-C, LDL-C, creatine 
phosphokinase-MB (CPK-MB) and troponin were 
significantly different in subjects with MetS 
compared to those free of MetS (P < 0.001).  
Table 2 shows among patients with MetS, low 
HDL-C (95%) was the most frequent component 
followed by increased waist circumference (82%), 
elevated FBS (76%), hypertension (HTN) (71%), 
and elevated TG (39%). The frequency of MetS 
components in all the subjects was as follows: Low 
HDL-C (80%), diabetes (70%), increased waist 
circumference (63%), HTN (50%), elevated TG 
(26%). Similar to the MetS group, low HDL-C was 
the most frequent finding (80%) in all the cases 
without MetS. Table 2 shows regardless of existing 
MetS, diabetic patients had significantly different 
Gensini scores (P < 0.001) and syntax scores  
(P = 0.007) compared to non-diabetic patients. 
Among hypertensive patients, only the syntax score 
was significantly different (P = 0.030) compared 
with normotensive patients while Gensini score  
(P = 0.900) showed no significant difference (data 
not shown).  
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Table 1. Demographic and biochemical parameters in the study patients 
Variable  Total 
MetS 
P 
Yes No 
Number 192 125 (65.0) 67 (35.0) 
 
Age     
Mean ± SD 65.00 ± 11.00 63.0 ± 11.00 68.00 ± 10.00 0.007
†
 
Median (range) 63 (44.00-85.00) 61 (44.00-85.00) 70 (46.00-82.00) 
 
Diastolic blood pressure     
Mean ± SD 81.00  ± 13.00 84.0 ± 14.00 75.00 ± 9.00 0.001
†
 
Median (range) 80 (40.00-140.00) 80 (40.00-140.00) 80 (60.00-90.00)  
Waist Circumference     
Mean ± SD 98.00  ± 11.00 102.0 ± 10.00 92.00 ± 9.00 < 0.001
†
 
Median (range) 98 (71.00-123.00) 102 (71.00-123.00) 89 (79.00-113.00)  
CPK     
Mean ± SD 1156.00 ± 1342.00 1509.0 ± 1462.00 499 ± 721 < 0.001
‡
 
Median (range) 642 (46.00-6400.00) 1222 (57.00-6400.00) 250 (46.00-2982.00) 
 
CPK-MB     
Mean ± SD 137.00 ± 154.00 170.0 ± 161.00 75.00 ± 117.00 < 0.001
‡
 
Median (range) 67 (15.00-696.00) 121 (20.00-696.00) 36 (15.00-510.00) 
 
Troponin     
Mean ± SD 0.96 ± 0.93 1.2 ± 0.92 0.51 ± 0.78 < 0.001
‡
 
Median (range) 0.87 (0.02-3.16) 1.17 (0.02-3.16) 0.03 (0.02-2.48) 
 
Fasting blood pressure     
Mean ± SD 136.00 ± 63.00 141.0 ± 61.00 126.00 ± 66.00 0.003
‡
 
Median (range) 118 (60.00-370.00) 129 (60.00-369.00) 101 (72.00-370.00) 
 
TG     
Mean ± SD 129 ± 75 143.0 ± 85.00 101.00 ± 38.00 < 0.001
‡
 
Median (range) 105 (57.00-511.00) 124 (57.00-511.00) 91 (60.00-189) 
 
HDL-C     
Mean ± SD 36.00 ± 7.00 34.0 ± 7.00 39.00 ± 7.00 < 0.001
†
 
Median (range) 36 (21.00-52.00) 35 (21.00-52.00) 41 (23.00-49.00) 
 
LDL-C     
Mean ± SD 97.00 ± 33.00 102.0 ± 33.00 88.00 ± 29.00 0.005
†
 
Median (range) 94 (11.00-208.00) 97 (29.00-208.00) 89 (11.00-124.00) 
 
Systolic blood pressure     
Mean ± SD 134.00 ± 28.00 141.0 ± 29.00 121.00 ± 22.00 <0.001
†
 
Median (range) 130 (70.00-240.00) 140 (70.00-240.00) 120 (85.00-190.00)  
Cholesterol     
Mean ± SD 162 ± 33 166.0 ± 38.00 154.00 ± 22.00 0.015
†
 
Median (range) 161 (90.00-280.00) 171 (98.00-280.00) 157 (90.00-183.00) 
 
Acute coronary artery disease     
STEMI [n (%)] 109 (56.8) 89 (71.2) 20 (29.9) < 0.001
*
 
Non STEMI [n (%)] 16 (8.3) 16 (12.8) 0 (0.0)  
USA [n (%)] 67 (34.9) 20 (16.0) 47 (70.1)  
Diabetes     
Yes [n (%)] 91 (47.4) 71 (56.8) 20 (29.9) < 0.001
*
 
No [n (%)] 101 (52.6) 54 (43.2) 47 (70.1)  
Sex     
Male [n (%)] 138 (71.9) 79 (63.2) 59 (88.1) < 0.001
*
 
Female [n (%)] 54 (28.1) 46 (36.8) 8 (11.9)  
Hypertension     
Yes [n (%)] 97 (50.5) 89 (71.2) 8 (11.9) < 0.001
*
 
No [n (%)] 95 (49.5) 36 (28.8) 59 (88.1) 
 * Based on chi-square test; †Based on Student’s t-test; ‡ Based on Mann-Whitney test  
MetS: Metabolic syndrome; STEMI: ST-elevation myocardial infarction; CPK: Creatine phosphokinase; TG: Triglyceride; LDL-C: 
Low-density lipoprotein-cholesterol; HDL-C: High-density lipoprotein-cholesterol; USA: Unstable angina; SD: Standard deviation 
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Table 2. Relationship between metabolic syndrome and angiographic severity of coronary artery disease 
Variable  Total 
MetS 
P 
Model 
1 
Model 
2 Yes No 
Gensini score Mean ± SD 6.7 ± 2.8 7.1 ± 2.6 5.9 ± 2.9 0.004
*
 0.137
£
 0.081
§
 
Syntax score Mean ± SD 13.7 ± 7.7 14.9 ± 6.6 11.5 ± 8.9 0.008
*
 0.020
£
 0.005
§
 
Ejection fraction Mean ± SD 45.5 ± 8.7 44.6 ± 8.8 47.4 ± 8.4 0.032
*
 0.018
£
 0.002
§
 
Angiographic results SVD [n(%)] 26 (13.5) 10 (8.0) 16 (23.9) < 0.001
**
 0.006
£
 0.003
£
 
 
2VD [n(%)] 77 (40.1) 53 (42.4) 24 (35.8) 
   
 
3VD [n(%)] 85 (44.3) 62 (49.6) 23 (34.3) 
   
 
LMS [n(%)] 4 (2.1) 0 (0.0) 4 (6.0) 
   
Medical treatment Medical treatment 
[n(%)] 
7 (3.6) 3 (2.4) 4 (6.0) 0.363
**
 0.101
£
 0.187
£
 
 
PCI [n(%)] 100 (52.1) 64 (51.2) 36 (53.7) 
   
  CABG [n(%)] 85 (44.3) 58 (46.4) 27 (40.3) 
   
Model 1: Adjusted for diabetes; Model 2: Adjusted for diabetes, age and sex; * Based on Student’s t-test; ** Based on Fisher exact 
test; § Based on analysis of covariance; £ Based on multinomial logistic regression; MetS: Metabolic syndrome; SVD: Single-vessel 
disease; 2VD: Two-vessel disease; 3VD: Three-vessel disease; LMS: Left main stem; PCI: Percutaneous coronary angiography; 
CABG: Coronary artery bypass graft; SD: Standard deviation 
 
ST-elevation myocardial infarction (STEMI) was 
more frequent in MetS group (P < 0.001). The fre-
quency of multi-vessel disease was higher in patients 
with MetS compared to those without it (P < 0.001 
and after adjustment P < 0.003). 
However, syntax score showed statistically 
significant difference between two groups before  
(P = 0.008) and after adjustment for diabetes  
(P = 0.020) and age and sex (P = 0.005). 
Concerning the ejection fraction, the same result 
was observed after adjustment for diabetes status 
and age and sex (P = 0.032, P = 0.018, P = 0.002, 
respectively) (data not shown). 
Discussion 
This study showed significant relationship between 
MetS and CAD severity according to angiography 
documents in Iranian subjects. In addition, we showed 
that presence of diabetes has significant effect on the 
CAD severity among subjects with MetS.  
Numerous studies have shown that MetS is able 
to predict cardiovascular events and diabetes, but 
there is argument about the role of MetS in 
cardiovascular risk among diabetic patients.20-23 Yoon 
et al. showed there is no relationship between MetS 
and coronary atherosclerosis in diabetic subjects.21 In 
addition, Sarrafzadegan et al. showed among 
symptomatic Korean population, MetS was 
independently associated with the presence and 
severity of CVD only in the non-diabetic subjects, 
and there was no significant difference between MetS 
group and non-MetS group regarding their age.24 
Similar to our results, Solymoss et al. showed 
that MetS was significantly related to more severe 
coronary angiographic alterations and higher 
frequencies of unstable angina, myocardial 
infarction, PCI, and CABG.18 Another important 
finding in our study was the 1.5 to 3 fold increased 
risk of new onset CVD in patients with MetS 
without diabetes.14  
In our study, there was significant difference 
between modified Gensini score and syntax score. 
This comparison showed that patients with MetS 
had more severe atherosclerosis in coronary arteries 
by both scores. 
After adjusting the effect of diabetes, syntax 
score was significantly associated with MetS, 
however the modified Gensini score did not have 
any significant association with MetS. Another 
important point is the effect of age. Patients 
without MetS were significantly older than other 
group; Gensini score had non-significant 
relationship with MetS whereas syntax score was 
significantly related to the MetS. So apparently 
modified Gensini score, which was used in this 
study, was a better predictor; also, the syntax score 
was more complete than modified Gensini score.18 
The syntax index assigns a heavier weight to the 
more severe luminal narrowing. Weights are also 
assigned to each segment depending on vessel size 
and importance; segments serving larger regions of 
myocardium are more heavily weighted.23-25 
Another probable cause, as mentioned earlier, is a 
semantic argument about the effects of diabetes on 
metabolic syndrome, which might have affected our 
results.23 
Also in MetS group, the patients had more 
multi-vessel disease and more acute events (STEMI 
versus unstable angina); although they were younger 
in comparison to MetS patients. 
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Conclusion 
MetS is strongly related to the severity of ACS 
presentation, documented clinically and 
angiographically in younger subjects. As such, control 
of MetS components is necessary in Iranian 
population. We recommend more studies with more 
participants and multicenter design and evaluation of 
Iranian lifestyle and MetS components, also utilizing 
complete Gensini score and other angiographic 
scores with larger samples. 
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